Related Experiment Video

Updated: Aug 11, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K

Best of 2022 in prostate cancer and prostatic diseases

Cosimo De Nunzio1, Riccardo Lombardo2

  • 1Sant'Andrea Hospital, Sapienza University of Rome, Urology, Rome, Italy. cosimodenunzio@virgilio.it.

Prostate Cancer and Prostatic Diseases
|February 4, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.4K
Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

45.9K

Related Experiment Videos

Last Updated: Aug 11, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.4K
Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

45.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

Articles linked to this work by shared authors, journal, and citation graph.

Comparison of effectiveness of a food supplement product versus Fosfomycin in the treatment of female recurrent urinary tract infections: Preliminary results of a multicenter comparative observational study.

Urologia·2026

A randomized controlled trial comparing alpha-blocker (tamsulosin) and a phyto-complex (Solidago virga-aurea, Phyllantus niruri, Epilobium angustifolium, Peumus boldus and Ononis spinosa) in the treatment of ureteral stent-related symptoms.

Urologia·2026

Treatment Regret in Patients Undergoing Minimally Invasive Treatments for Benign Prostatic Hyperplasia.

Journal of clinical medicine·2026

Evaluation and management of transient lower urinary tract symptoms (LUTS) after surgery for Benign prostatic obstruction (BPO): a systematic review.

Prostate cancer and prostatic diseases·2026

Trends and incidence of reported events associated with staplers: an analysis of the food and drug administration's manufacturer and user facility device experience database.

Updates in surgery·2026

How Could the Proposed International Continence Society (ICS) Global Urodynamics Data Repository (GUDRep) Demonstrate the Clinical Role and Cost Effectiveness of Urodynamics in Individual Patients? ICI-RS 2025.

Neurourology and urodynamics·2025

Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer.

Prostate cancer and prostatic diseases·2026

Oncological and functional outcomes of focal irreversible electroporation for localised prostate cancer: a single institution series of 171 cases.

Prostate cancer and prostatic diseases·2026

Correlation of intraprostatic lesional SUVmax during PSMA PET/CT and adverse pathology at radical prostatectomy.

Prostate cancer and prostatic diseases·2026

Prostate size and its effect on sexual function following convective water vapor thermal therapy.

Prostate cancer and prostatic diseases·2026

Successful cabazitaxel desensitization after severe taxane hypersensitivity reactions: a brief report.

Prostate cancer and prostatic diseases·2026

Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.

Prostate cancer and prostatic diseases·2026

Receptor Co‑targeting Strategies for Personalized Ovarian Cancer Therapy.

International journal of nanomedicine·2026

Nuclear export inhibition activates TP53 pathways and is a potent therapeutic strategy in atypical teratoid rhabdoid tumors.

Neuro-oncology advances·2026

Heat Shock Proteins in Cancer: Mechanisms and Therapeutic Targeting.

MedComm·2026

A germline KDM3C polymorphism impairs DNA repair and sensitizes to chemoradiotherapy.

medRxiv : the preprint server for health sciences·2026

Protective Effect of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) on Liver Function: Results From MELD Analysis in Surgical Revascularization-A Preliminary Study.

Medical science monitor : international medical journal of experimental and clinical research·2026

Budget Impact of Prophylactic Letermovir to Prevent Cytomegalovirus Disease in High-Risk Adult Kidney Transplant Recipients.

PharmacoEconomics - open·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us